Subsequently, we further evaluated the endogenous KIF4A expression in 492 (86.6%) of 568 CRC samples and 493 (86.8%) of 568 non-tumor tissues in the TMAs using immunohistochemistry (IHC). The gene discussed is KIF4A; the disease is colorectal carcinoma.